Abstract:This article highlights the potential of azole derivatives in cancer therapy, focusing on their ability to target cancer cells and disrupt key biological pathways. It discusses recent advances, structural modifications, and ongoing research aimed at enhancing their anticancer efficacy. The review accentuates the therapeutic promise of azoles in developing innovative treatments for cancer. Monocyclic 5‐membered heterocycles including imidazoles, thiazoles, oxazoles, and their related compounds have gained significant attention in medicinal chemistry because of their potent anticancerous activity. These small heterocyclic molecules possess versatile properties, including biological activity, absorption, distribution, metabolism, excretion, and chemical diversity that give them immense potential as anticancer agents. It is also a fact that inherent characteristic of azoles to combine with many biological molecules through hydrogen bond, stacking, and hydrophobic interaction makes them effective against almost all cancer types. In the present paper the author discusses the way which is connected with chemical structure of monocyclic azoles and their anticancer activity namely the ability of these compounds to intercalate with DNA, to inhibit some enzymes and to interfere cellular signaling pathways. Interestingly, several azole derivatives have been seen to be effective in preclinical efficacy studies as well as in clinical trials and are considered to be potent in overcoming the problem of resistance and side effects of the common anticancer agents. As the synthetic chemistry progresses, the structural system of the azoles has diversified and development in the pharmacology has become more specific. This has helped in enhancing the formation of new molecules in the azole class with improved selectivity and efficacy. Furthermore, the comprehensive review explains how computational chemistry and structure‐activity relationship (SAR) approaches are applied to the design of future‐generation azole compounds. In light of these facts, this article is designed to give a broad overview of the current state of monocyclic azole‐based anticancer agents in an attempt to further assert its therapeutic promise and spur further attempts at infusing the said agents into the cancer therapeutics fray. The discoveries made in this study may allow the development the radical different therapeutic approaches, which could lead to improved and targeted treatment of cancer.

Benzimidazole based derivatives as anticancer agents: Structure activity relationship analysis for various targets

Benzimidazole: A Multifacted Nucelus for Anticancer Agents

Exploring the molecular insights of imidazole and benzimidazole scaffold for cancer therapy: Synthesis, in-vitro cytotoxicity and SAR studies

Unlocking the Pharmacological Potential of Benzimidazole Derivatives: A Pathway to Drug Development

Sabaratnam Arulkumaran: Dreaming of entering politics

[Strategies for cerebrospinal fluid analysis - Integrated results report].

Significance of Benzimidazole analogues for the creation of novel molecules in drug discovery

Structure–Activity Relationship of Benzofuran Derivatives with Potential Anticancer Activity

Synthesis, Structure-Activity Relationship, and Biological Activity of Benzimidazole-Quinoline: A Review to Aid in the Design of a New Drug

CD20-negative CD138-positive leukemic large cell lymphoma with plasmablastic differentiation with an IgH/MYC translocation in an HIV-positive patient.

Imidazolidinones Derivatives As Pioneering Anticancer Agents: Unraveling Insights Through synthesis And Structure‐Activity Exploration

In silico Approaches for Exploring the Pharmacological Activities of Benzimidazole Derivatives: A Comprehensive Review

Design of New Benzo[h]chromene Derivatives: Antitumor Activities and Structure-Activity Relationships of the 2,3-Positions and Fused Rings at the 2,3-Positions

Azole Derivatives: Cutting‐Edge Agents in Cancer Therapy

N-Aryl Benzimidazole and Benzotriazole Derivatives and Their Hybrids as Cytotoxic Agents: Design, Synthesis and Structure–Activity Relationship Studies

Development of drugs based on imidazole and benzimidazole bioactive heterocycles: recent advances and future directions

Benzothiazole‐based apoptosis inducers: A comprehensive overview and future prospective

Anticancer potential and structure activity studies of purine and pyrimidine derivatives: an updated review

Synthesis and anticancer activity of 1,2,4-Benzothiadiazine-1,1-dioxides

Benzimidazole: A Versatile Scaffold for Drug Discovery and Beyond - A Comprehensive Review of Synthetic Approaches and Recent Advancements in Medicinal Chemistry

Diaryl-substituted benzimidazole derivatives as antiproliferative agents: Design, synthesis, in vitro activity, and SAR analysis